全文获取类型
收费全文 | 81843篇 |
免费 | 6808篇 |
国内免费 | 4797篇 |
出版年
2024年 | 99篇 |
2023年 | 823篇 |
2022年 | 2146篇 |
2021年 | 3731篇 |
2020年 | 2435篇 |
2019年 | 2944篇 |
2018年 | 2958篇 |
2017年 | 2112篇 |
2016年 | 3017篇 |
2015年 | 4873篇 |
2014年 | 5573篇 |
2013年 | 6211篇 |
2012年 | 7226篇 |
2011年 | 6690篇 |
2010年 | 3987篇 |
2009年 | 3478篇 |
2008年 | 4260篇 |
2007年 | 3777篇 |
2006年 | 3295篇 |
2005年 | 2791篇 |
2004年 | 2342篇 |
2003年 | 2023篇 |
2002年 | 1785篇 |
2001年 | 1573篇 |
2000年 | 1573篇 |
1999年 | 1461篇 |
1998年 | 859篇 |
1997年 | 811篇 |
1996年 | 810篇 |
1995年 | 741篇 |
1994年 | 690篇 |
1993年 | 536篇 |
1992年 | 822篇 |
1991年 | 667篇 |
1990年 | 607篇 |
1989年 | 532篇 |
1988年 | 423篇 |
1987年 | 366篇 |
1986年 | 344篇 |
1985年 | 302篇 |
1984年 | 224篇 |
1983年 | 200篇 |
1982年 | 114篇 |
1981年 | 122篇 |
1980年 | 90篇 |
1979年 | 149篇 |
1978年 | 84篇 |
1977年 | 97篇 |
1975年 | 113篇 |
1974年 | 116篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
62.
R H?kanson D Chen E Lindstr?m P Norlén M Bj?rkqvist D Lehto-Axtelius 《The Yale journal of biology and medicine》1998,71(3-4):163-171
The enterochromaffin-like (ECL) cells of the oxyntic mucosa (fundus) of the stomach produce, store and secrete histamine, chromogranin A-derived peptides such as pancreastatin, and an unanticipated but as yet unidentified peptide hormone. The cells are stimulated by gastrin and pituitary adenylate cyclase activating peptide and suppressed by somatostatin and galanin. Choline esters and histamine seem to be without effect on ECL cell secretion. The existence of a gastrin-ECL cell axis not only explains how gastrin stimulates acid secretion but also may help to explore the functional significance of the ECL cells with respect to the nature and bioactivity of its peptide hormone. From the results of studies of gastrectomized/fundectomized and gastrin-treated rats, it has been speculated that the anticipated ECL-cell peptide hormone acts on bone metabolism. 相似文献
63.
64.
65.
Lysine acetylation, one of the major types of post-translational modifications, plays critical roles in regulating gene expression and protein function. Histone deacetylases(HDACs) are responsible for removing acetyl groups from lysines of both histone and non-histone proteins. While tremendous progress has been made in understanding the function and mechanism of HDACs in animals in the past two decades, nearly half of the HDAC studies in plants were reported within the past five years. In this review,we summarize the major findings on plant HDACs, with a focus on the model plant Arabidopsis thaliana, and highlight the components, regulatory mechanisms, and biological functions of HDAC complexes. 相似文献
66.
Jian Xiao Dan Chen Xiu-Xian Lin Shi-Fang Peng Mei-Fang Xiao Wei-Hua Huang Yi-Cheng Wang Jing-Bo Peng Wei Zhang Dong-Sheng Ouyang Yao Chen 《PloS one》2016,11(2)
Ginsenoside compound K (CK), a rare ginsenoside originating from Panax Ginseng, has been found to possess unique pharmacological activities specifically as anti-cancers. However, the role of cytochrome P450s (CYPs) in the metabolism of CK is unclear. In this study, we screened the CYPs for the metabolism of CK in vitro using human liver microsomes (HLMs) or human recombinant CYPs. The results showed that CK inhibited the enzyme activities of CYP2C9 and CYP3A4 in the HLMs. The Km and Vmax values of CK were 84.20±21.92 μM and 0.28±0.04 nmol/mg protein/min, respectively, for the HLMs; 34.63±10.48 μM and 0.45±0.05 nmol/nmol P450/min, respectively, for CYP2C9; and 27.03±5.04 μM and 0.68±0.04 nmol/nmol P450/min, respectively, for CYP3A4. The IC50 values were 16.00 μM and 9.83 μM, and Ki values were 14.92 μM and 11.42μM for CYP2C9 and CYP3A4, respectively. Other human CYP isoforms, including CYP1A2, CYP2A6, CYP2D6, CYP2E1, and CYP2C19, showed minimal or no effect on CK metabolism. The results suggested that CK was a substrate and also inhibitors for both CYP2C9 and CYP3A4. Patients using CK in combination with therapeutic drugs that are substrates of CYP2C9 and CYP3A4 for different reasons should be careful, although the inhibiting potency of CK is much poorer than that of enzyme-specific inhibitors. 相似文献
67.
Development and Phase 3 testing of the most advanced malaria vaccine, RTS,S/AS01, indicates that malaria vaccine R&D is moving into a new phase. Field trials of several research malaria vaccines have also confirmed that it is possible to impact the host-parasite relationship through vaccine-induced immune responses to multiple antigenic targets using different platforms. Other approaches have been appropriately tested but turned out to be disappointing after clinical evaluation. As the malaria community considers the potential role of a first-generation malaria vaccine in malaria control efforts, it is an apposite time to carefully document terminated and ongoing malaria vaccine research projects so that lessons learned can be applied to increase the chances of success for second-generation malaria vaccines over the next 10 years. The most comprehensive resource of malaria vaccine projects is a spreadsheet compiled by WHO thanks to the input from funding agencies, sponsors and investigators worldwide. This spreadsheet, available from WHO's website, is known as "the rainbow table". By summarizing the published and some unpublished information available for each project on the rainbow table, the most comprehensive review of malaria vaccine projects to be published in the last several years is provided below. 相似文献
68.
Lauren Petrullo Matthew J. Jorgensen Noah Snyder‐Mackler Amy Lu 《American journal of primatology》2019,81(10-11)
The human milk microbiome is vertically transmitted to offspring during the postnatal period and has emerged as a critical driver of infant immune and metabolic development. Despite this importance in humans, the milk microbiome of nonhuman primates remains largely unexplored. This dearth of comparative work precludes our ability to understand how species‐specific differences in the milk microbiome may differentially drive maternal effects and limits how translational models can be used to understand the role of vertically transmitted milk microbes in human development. Here, we present the first culture‐independent data on the milk microbiome of a nonhuman primate. We collected milk and matched fecal microbiome samples at early and late lactation from a cohort of captive lactating vervet monkeys (N = 15). We found that, similar to humans, the vervet monkey milk microbiome comprises a shared community of taxa that are universally present across individuals. However, unlike in humans, this shared community is dominated by the genera Lactobacillus, Bacteroides, and Prevotella. We also found that, in contrast to previous culture‐dependent studies in humans, the vervet milk microbiome exhibits greater alpha‐diversity than the gut microbiome across lactation. Finally, we did not find support for the translocation of microbes from the gut to the mammary gland within females (i.e., “entero‐mammary pathway”). Taken together, our results show that the vervet monkey milk microbiome is taxonomically diverse, distinct from the gut microbiome, and largely stable. These findings demonstrate that the milk microbiome is a unique substrate that may selectively favor the establishment and persistence of particular microbes across lactation and highlights the need for future experimental studies on the origin of microbes in milk. 相似文献
69.
70.
K W Culver W T Hsieh Y Huyen V Chen J Liu Y Khripine A Khorlin 《Nature biotechnology》1999,17(10):989-993
A sequence-specific genomic delivery system for the correction of chromosomal mutations was designed by incorporating two different binding domains into a single-stranded oligonucleotide. A repair domain (RD) contained the native sequence of the target region. A third strand-forming domain (TFD) was designed to form a triplex by Hoogsteen interactions. The design was based upon the premise that the RD will rapidly form a heteroduplex that is anchored synergistically by the TFD. Deoxyoligonucleotides were designed to form triplexes in the human adenosine deaminase (ADA) and p53 genes adjacent to known point mutations. Transfection of ADA-deficient human lymphocytes corrected the mutant sequence in 1-2% of cells. Neither the RD or TFD individually corrected the mutation. Transfection of p53 mutant human glioblastoma cells corrected the mutation and induced apoptosis in 7.5% of cells. 相似文献